These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thrombopoietin: biology and clinical potentials. Miyazaki H; Kato T Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146 [TBL] [Abstract][Full Text] [Related]
5. The biology of thrombopoietin and thrombopoietin receptor agonists. Kuter DJ Int J Hematol; 2013 Jul; 98(1):10-23. PubMed ID: 23821332 [TBL] [Abstract][Full Text] [Related]
6. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. Deutsch VR; Tomer A Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368 [TBL] [Abstract][Full Text] [Related]
7. [Clinical use of recombinant human thrombopoietin. Status and perspectives]. Hansen PB; Hasselbalch HC Ugeskr Laeger; 2001 May; 163(19):2659-62. PubMed ID: 11360368 [TBL] [Abstract][Full Text] [Related]
8. Clinical findings with the first generation of thrombopoietic agents. Vadhan-Raj S Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436 [TBL] [Abstract][Full Text] [Related]
9. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation. Matsuki E; Miyakawa Y; Yamane A; Okamoto S Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620 [TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura. Gernsheimer TB Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086 [TBL] [Abstract][Full Text] [Related]
11. What is the potential for thrombopoietic agents in acute leukemia? Kuter DJ Best Pract Res Clin Haematol; 2011 Dec; 24(4):553-8. PubMed ID: 22127320 [TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin from beginning to end. Hitchcock IS; Kaushansky K Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199 [TBL] [Abstract][Full Text] [Related]
13. Secretion expression and activity assay of a novel fusion protein of thrombopoietin and interleukin-6 in Pichia pastoris. Zhiyi H; Wenshan L; Wenze Z; Ning D; Chi Z; Kenan Y; Ping W; Qianqian W; Qing Z J Biochem; 2007 Jul; 142(1):17-24. PubMed ID: 17517790 [TBL] [Abstract][Full Text] [Related]
14. [Megakaryopoiesis: regulation of platelet production by thrombopoietin]. Vainchenker W; Besancenot R; Favale F Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369 [TBL] [Abstract][Full Text] [Related]
15. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling. Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013 [TBL] [Abstract][Full Text] [Related]
16. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist. Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407 [TBL] [Abstract][Full Text] [Related]
17. The physiology of platelet production. Kuter DJ Stem Cells; 1996; 14 Suppl 1():88-101. PubMed ID: 11012207 [TBL] [Abstract][Full Text] [Related]